{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:20:21Z","timestamp":1782991221803,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.genhosppsych.2025.06.010","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:10:14Z","timestamp":1750792214000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk of self-harm and overdose after starting buprenorphine for opioid use disorder"],"prefix":"10.1016","volume":"96","author":[{"given":"Gregory E.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Shortreed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulin C.","family":"Hechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Ziebell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujaya","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.genhosppsych.2025.06.010_bb0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.20230397","article-title":"National trends in emergency department visits for suicide attempts and intentional self-harm","volume":"181","author":"Bommersbach","year":"2024","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0010","series-title":"Drug abuse warning network (DAWN): findings from drug-related emergency department visits 2022","author":"Center for Behavioral Health Statistics and Quality","year":"2023"},{"issue":"17","key":"10.1016\/j.genhosppsych.2025.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMp1801417","article-title":"Suicide: a silent contributor to opioid-overdose deaths","volume":"378","author":"Oquendo","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.06.010_bb0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/appi.ajp.2018.17101167","article-title":"Predicting suicide attempts and suicide deaths following outpatient visits using electronic health records","volume":"175","author":"Simon","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.06.010_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","article-title":"Prescription opioid analgesics increase the risk of depression","volume":"29","author":"Scherrer","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"6\u20137","key":"10.1016\/j.genhosppsych.2025.06.010_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.addbeh.2009.01.002","article-title":"Gender and comorbidity among individuals with opioid use disorders in the NESARC study","volume":"34","author":"Grella","year":"2009","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.06.010_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/pm\/pny228","article-title":"International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering","volume":"20","author":"Darnall","year":"2019","journal-title":"Pain Med"},{"issue":"Suppl","key":"10.1016\/j.genhosppsych.2025.06.010_bb0045","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.drugalcdep.2004.08.003","article-title":"Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies","volume":"76","author":"Wilcox","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.06.010_bb0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/add.13774","article-title":"Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration","volume":"112","author":"Bohnert","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2017.03.011","article-title":"Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts","volume":"92","author":"Ashrafioun","year":"2017","journal-title":"J Psychiatr Res"},{"issue":"10182","key":"10.1016\/j.genhosppsych.2025.06.010_bb0060","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13063-018-2843-9","article-title":"The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0070","first-page":"58","article-title":"Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: a randomized, double blind, placebo-controlled study","volume":"32","author":"Ahmadi","year":"2020","journal-title":"Ci Ji Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.06.010_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","article-title":"Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial","volume":"173","author":"Yovell","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.06.010_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082410","article-title":"The efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: a systematic review","volume":"19","author":"Serafini","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.06.010_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/pharma1030010","article-title":"Evaluation of the effectiveness of buprenorphine-naloxone on opioid overdose and death among insured patients with opioid use disorder in the United States","volume":"1","author":"Sun","year":"2022","journal-title":"Pharmacoepidemiology"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.06.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.06.010_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1176\/appi.ajp.2021.21070700","article-title":"Association of medication treatment for opioid use disorder with suicide mortality","volume":"179","author":"Watts","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.06.010_bb0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0105","doi-asserted-by":"crossref","unstructured":"Santo T.J. Jr., Chaillon A., Martin N., Hickman M., Jones N., Farrell M., et al. Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: a data-modeling study. Addiction 2025 (online ahead of print) DOI: 10.1111\/add.70018.","DOI":"10.1111\/add.70018"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.06.010_bb0110","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1176\/appi.ajp.2018.17101112","article-title":"Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime","volume":"175","author":"Molero","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0115","article-title":"Improving pragmatic clinical trial design using real-world data","volume":"1740774519833679","author":"Shortreed","year":"2019","journal-title":"Clin Trials"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.06.010_bb0120","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.2022.0423","article-title":"Effect of offering care management or online dialectical behavior therapy skills training vs usual care on self-harm among adult outpatients with suicidal ideation: a randomized clinical trial","volume":"327","author":"Simon","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0125","doi-asserted-by":"crossref","unstructured":"Hernan M.A., Dahabreh I.J., Dickerman B.A., Swanson S.A. The target trial framework for causal inference from observational data: why and when is it helpful? Ann Intern Med 2025 Epub 2025 Feb 18.","DOI":"10.7326\/ANNALS-24-01871"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.06.010_bb0130","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hernan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0140","doi-asserted-by":"crossref","DOI":"10.13063\/2327-9214.1049","article-title":"The HMO research network virtual data warehouse: a public data model to support collaboration","volume":"2","author":"Ross","year":"2014","journal-title":"eGEMs"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.06.010_bb0145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ps.201500217","article-title":"Racial-ethnic differences in psychiatric diagnoses and treatment across 11 health care systems in the mental health research network","volume":"67","author":"Coleman","year":"2016","journal-title":"Psychiatr Serv"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.06.010_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajem.2023.04.005","article-title":"COVID-19 pandemic-associated changes in overall emergency department visits by age group, race, and ethnicity - United States, January 2019-April 2022","volume":"69","author":"Smith","year":"2023","journal-title":"Am J Emerg Med"},{"issue":"21","key":"10.1016\/j.genhosppsych.2025.06.010_bb0160","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.2024.16954","article-title":"Buprenorphine\/naloxone vs methadone for the treatment of opioid use disorder","volume":"332","author":"Nosyk","year":"2024","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.06.010_bb0165","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/appi.ajp.2018.17101167","article-title":"1). Predicting suicide attempts and suicide deaths following outpatient visits using electronic health records","volume":"175","author":"Simon","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.06.010_bb0170","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/jamia\/ocac144","article-title":"Accuracy of ICD-10-CM encounter diagnoses from health records for identifying self-harm events","volume":"29","author":"Simon","year":"2022","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.06.010_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/appi.ps.201600450","article-title":"Changes in coding of suicide attempts or self-harm with transition from ICD-9 to ICD-10","volume":"68","author":"Stewart","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"8","key":"10.1016\/j.genhosppsych.2025.06.010_bb0180","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pds.4772","article-title":"Identifying and classifying opioid-related overdoses: a validation study","volume":"28","author":"Green","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0962280208092347","article-title":"Use of disease risk scores in pharmacoepidemiologic studies","volume":"18","author":"Arbogast","year":"2009","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41746-023-00772-4","article-title":"Complex modeling with detailed temporal predictors does not improve health records-based suicide risk prediction","volume":"6","author":"Shortreed","year":"2023","journal-title":"NPJ Digit Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.06.010_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after nonfatal opioid overdose: reduced mortality risk in Medicare disability beneficiaries","volume":"65","author":"Samples","year":"2023","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.06.010_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.06.010_bb0205","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2022.3118","article-title":"Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder","volume":"79","author":"Gibbons","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.06.010_bb0210","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/add.15959","article-title":"Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study","volume":"117","author":"Burns","year":"2022","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.06.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11363","article-title":"Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.06.010_bb0220","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.06.010_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.06.010_bb0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1027\/0227-5910\/a000499","article-title":"Suicidal behavior and non-suicidal self-injury in emergency departments underestimated by administrative claims data","volume":"39","author":"Stanley","year":"2018","journal-title":"Crisis"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.06.010_bb0240","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021","volume":"118","author":"Friedman","year":"2023","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.06.010_bb0245","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.06.010_bb0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajem.2022.05.013","article-title":"Buprenorphine precipitated opioid withdrawal: prevention and management in the ED setting","volume":"58","author":"Spadaro","year":"2022","journal-title":"Am J Emerg Med"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:37:31Z","timestamp":1757335051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S0163834325001355"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.06.010","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of self-harm and overdose after starting buprenorphine for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}